TY - JOUR PY - 2020// TI - Epidemiology of sudden death in a population-based study of infants and children JO - Journal of pediatrics: X A1 - Burns, Kristin M. A1 - Cottengim, Carri A1 - Dykstra, Heather A1 - Faulkner, Meghan A1 - Lambert, Alexa B. Erck A1 - MacLeod, Heather A1 - Novak, Alissa A1 - Parks, Sharyn E. A1 - Russell, Mark W. A1 - Shapiro-Mendoza, Carrie K. A1 - Shaw, Esther A1 - Tian, Niu A1 - Whittemore, Vicky A1 - Kaltman, Jonathan R. A1 - Sudden Death in the Young Case Registry, SP - e100023 EP - e100023 VL - 2 IS - N2 - OBJECTIVE: To describe epidemiologic data from the Sudden Death in the Young (SDY) Case Registry. Understanding the scope of SDY may optimize prevention efforts. Study design: We analyzed sudden, unexpected deaths of infants (<365 days) and children (1-17 years) from a population-based registry of 8 states/jurisdictions in 2015 and 9 in 2016. Natural deaths and injury deaths from drowning, motor vehicle accident drivers, and infant suffocation were included; other injury deaths, homicide, suicide, intentional overdose, and terminal illness were excluded. Cases were categorized using a standardized algorithm. Descriptive statistics were used to characterize deaths, and mortality rates were calculated. Results: Of 1319 cases identified, 92% had an autopsy. We removed incomplete cases, leaving 1132 analyzable deaths (889 infants, 243 children). The SDY rate for infants was 120/100 000 live births and for children was 1.9/100 000 children. Explained Cardiac rates were greater for infants (2.7/100 000 live births) than children (0.3/100 000 children). The pediatric Sudden Unexpected Death in Epilepsy (SUDEP) mortality rate was 0.2/100 000 live births and children. Blacks comprised 42% of infant and 43% of child deaths but only 23% of the population. In all ages, myocarditis/endocarditis was the most common Explained Cardiac cause; respiratory illness was the most common Explained Other cause. SDY occurred during activity in 13% of childhood cases. Conclusions: Prevention strategies include optimizing identification and treatment of respiratory and cardiac diseases.
Language: en
LA - en SN - 2590-0420 UR - http://dx.doi.org/10.1016/j.ympdx.2020.100023 ID - ref1 ER -